ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment
A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as…
Browsing: ASCO
ASCO 2023: Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
Updated dose expansion data of the phase I STRO-002-GM1 study were presented today by Ana Oaknin, Principal…
ASCO 2023: Ciltacabtagene autoleucel reduces risk of disease progression by 74% in multiple myeloma after lenalidomide stops working
Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma…
ASCO 2023: Axi-cel improves survival in early large B-cell lymphoma
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric…
ASCO 2023: Radiotherapy may not be necessary after chemoimmunotherapy for primary mediastinal B-cell lymphoma
Results from the largest prospective study of primary mediastinal B-cell lymphoma show that radiation therapy…
ASCO 2023: Multi-cancer blood test shows real promise
The SYMPLIFY study is the first large-scale evaluation of a multi-cancer early detection (MCED) test in individuals…
ASCO 2023: Global study finds simple hysterectomy a safe option for people with early-stage, low-risk cervical cancer
“For patients with stage 1 cervical cancer who are eligible for surgery, radical hysterectomy has…
ASCO 2023: Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel
Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet…
ASCO 2023: Osimertinib after surgery significantly improves survival in patients with resected EGFR-mutated non-small cell lung cancer
Treatment with osimertinib after surgery significantly lowered the risk of death in adults with completely…
ASCO 2023: Study may provide clues to treating colorectal cancer more effectively in younger patients
While the incidence of colorectal cancer (CRC) has dropped significantly among older adults in recent…